Ajax-Loading

AstraZeneca PLC - Ebit Interest Coverage

AstraZeneca PLC's Fiscal Year is From January To December.

The item "Ebit-Interest-Coverage" stands at 5.94 as of 09/30/2025.

As of the end of AstraZeneca PLC's third quarter, the item "Ebit Interest Coverage" stands at 5.94. This represents an increase of 24.24 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.4433 compared to the value the year prior.
The Serie's long term average value is 4.11. It's latest available value, on 09/30/2025, is 1.83 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +6.33 .
The Serie's change from it's maximum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is -0.0577 .

Ebit Interest Coverage for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebit Interest Coverage905,699,262,464.00
LogoJohnson & Johnson - Ebit Interest Coverage486,508,953,600.00
LogoAbbVie Inc - Ebit Interest Coverage399,570,305,024.00
LogoRoche Holding AG - Ebit Interest Coverage317,433,206,677.55
LogoNovartis AG - Ebit Interest Coverage255,096,620,580.91